Tag Archives: Dow Chemical

Process Development at AIChE 2010

While reviewing the agenda for next month’s American Institute of Chemical Engineers (AIChE) Annual Meeting, I noticed a number of papers and posters discussing process development in pharmaceuticals, chemicals, and academia: Continue reading

Chemical & Engineering News: Highlighting Recent Letters Discussing Chemical Process Safety

A few months ago, I came across two letters in Chemical & Engineering News that I would like to bring to your attention. Both letters relate to ensuring the safety of chemical processes.

The first, from Tom Vickery and colleagues at Merck, made the point that a recently published procedure (for preparation of 2-bromo-3-methylbutenal) presents a safety issue with dramatic consequences for scale-up:

Continue reading